Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quality of Life | 6 | 2024 | 837 | 2.120 |
Why?
|
| Infant, Extremely Premature | 2 | 2023 | 36 | 1.650 |
Why?
|
| Intellectual Disability | 2 | 2022 | 124 | 1.430 |
Why?
|
| Autistic Disorder | 2 | 2022 | 121 | 1.420 |
Why?
|
| Hemiarthroplasty | 1 | 2024 | 7 | 0.950 |
Why?
|
| Chromosome Disorders | 1 | 2021 | 35 | 0.740 |
Why?
|
| Perinatal Care | 1 | 2016 | 26 | 0.520 |
Why?
|
| Cerebral Palsy | 1 | 2016 | 40 | 0.510 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2023 | 47 | 0.410 |
Why?
|
| Birth Weight | 2 | 2023 | 120 | 0.410 |
Why?
|
| Health Priorities | 1 | 2012 | 19 | 0.410 |
Why?
|
| Child | 5 | 2023 | 6854 | 0.400 |
Why?
|
| Safety Management | 1 | 2012 | 38 | 0.400 |
Why?
|
| Hospital Costs | 1 | 2012 | 71 | 0.390 |
Why?
|
| Health Services Research | 1 | 2012 | 151 | 0.380 |
Why?
|
| Quality of Health Care | 1 | 2012 | 184 | 0.360 |
Why?
|
| Caregivers | 2 | 2022 | 211 | 0.340 |
Why?
|
| Prospective Studies | 2 | 2023 | 2379 | 0.280 |
Why?
|
| Humans | 12 | 2024 | 50251 | 0.270 |
Why?
|
| Infant, Newborn | 2 | 2023 | 2767 | 0.250 |
Why?
|
| Cementation | 1 | 2024 | 7 | 0.240 |
Why?
|
| Femoral Neck Fractures | 1 | 2024 | 8 | 0.240 |
Why?
|
| Bone Cements | 1 | 2024 | 31 | 0.230 |
Why?
|
| Young Adult | 3 | 2023 | 4002 | 0.230 |
Why?
|
| Parent-Child Relations | 1 | 2022 | 72 | 0.200 |
Why?
|
| Parenting | 1 | 2022 | 105 | 0.190 |
Why?
|
| Adolescent | 2 | 2023 | 6402 | 0.190 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2024 | 262 | 0.180 |
Why?
|
| Mental Health | 1 | 2022 | 219 | 0.170 |
Why?
|
| Parents | 1 | 2022 | 314 | 0.170 |
Why?
|
| Adult | 3 | 2023 | 13384 | 0.150 |
Why?
|
| Smoking Cessation | 1 | 2021 | 298 | 0.150 |
Why?
|
| Pandemics | 1 | 2022 | 567 | 0.150 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 3140 | 0.140 |
Why?
|
| Quebec | 1 | 2016 | 13 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 71 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2024 | 5186 | 0.130 |
Why?
|
| Propensity Score | 1 | 2016 | 121 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 186 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 47 | 0.110 |
Why?
|
| Lymphoma, Follicular | 1 | 2012 | 27 | 0.110 |
Why?
|
| Middle Aged | 3 | 2024 | 12234 | 0.100 |
Why?
|
| Male | 3 | 2024 | 25483 | 0.100 |
Why?
|
| Mass Screening | 1 | 2014 | 346 | 0.100 |
Why?
|
| Female | 3 | 2024 | 26668 | 0.090 |
Why?
|
| Aged | 1 | 2024 | 9427 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 3 | 2016 | 271 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 1169 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 609 | 0.080 |
Why?
|
| Canada | 2 | 2016 | 101 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2016 | 63 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 1186 | 0.060 |
Why?
|
| Ontario | 1 | 2021 | 49 | 0.050 |
Why?
|
| Electronic Mail | 1 | 2021 | 18 | 0.050 |
Why?
|
| Telephone | 1 | 2021 | 69 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2021 | 360 | 0.040 |
Why?
|
| Remission Induction | 1 | 2016 | 207 | 0.030 |
Why?
|
| Recurrence | 1 | 2016 | 661 | 0.030 |
Why?
|
| Genomics | 1 | 2016 | 287 | 0.030 |
Why?
|
| Models, Economic | 1 | 2012 | 17 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 168 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 544 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 454 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 567 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 902 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 3608 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 2911 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2016 | 6172 | 0.010 |
Why?
|